Tempest Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2012 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Tempest Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2012 to Q3 2024.
  • Tempest Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 8, 2024 was 43.6M shares, a 127% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 43.6M +24.4M +127% Nov 8, 2024 10-Q 2024-11-12
Q2 2024 25.2M +11.9M +89.2% Aug 5, 2024 10-Q 2024-08-08
Q1 2024 22.2M +11.6M +110% Mar 13, 2024 10-K 2024-03-19
Q3 2023 19.2M +8.73M +83% Nov 7, 2023 10-Q 2023-11-08
Q2 2023 13.3M +2.91M +27.9% Aug 7, 2023 10-Q 2023-08-10
Q1 2023 10.6M +3.39M +47.2% Mar 16, 2023 10-K 2023-03-22
Q3 2022 10.5M +3.61M +52.2% Nov 2, 2022 10-Q 2022-11-08
Q2 2022 10.4M +3.72M +55.4% Aug 10, 2022 10-Q 2022-08-15
Q1 2022 7.17M -11.9M -62.3% Mar 15, 2022 10-K/A 2022-04-01
Q3 2021 6.91M -12.1M -63.6% Nov 8, 2021 10-Q 2021-11-10
Q2 2021 6.7M -12.3M -64.7% Aug 10, 2021 10-Q 2021-08-12
Q1 2021 19M +776K +4.25% Mar 15, 2021 10-K/A 2021-04-29
Q3 2020 19M +5.53M +41% Nov 3, 2020 10-Q 2020-11-09
Q2 2020 19M +5.59M +41.7% Aug 4, 2020 10-Q 2020-08-10
Q1 2020 18.3M +4.91M +36.7% Mar 1, 2020 10-K 2020-03-11
Q3 2019 13.5M -22.4M -62.4% Nov 8, 2019 10-Q 2019-11-13
Q2 2019 13.4M -22.4M -62.5% Aug 9, 2019 10-Q 2019-08-12
Q1 2019 13.4M -22.4M -62.6% Mar 1, 2019 10-K 2019-04-01
Q3 2018 35.8M +121K +0.34% Nov 6, 2018 10-Q 2018-11-09
Q2 2018 35.8M +103K +0.29% Aug 6, 2018 10-Q 2018-08-09
Q1 2018 35.7M +83.7K +0.24% Mar 13, 2018 10-K 2018-03-15
Q3 2017 35.7M +97.3K +0.27% Oct 30, 2017 10-Q 2017-11-02
Q2 2017 35.7M +125K +0.35% Jul 31, 2017 10-Q 2017-08-03
Q1 2017 35.6M +8.31M +30.4% Feb 27, 2017 10-K 2017-03-02
Q3 2016 35.6M +8.33M +30.5% Nov 1, 2016 10-Q 2016-11-03
Q2 2016 35.6M +8.29M +30.4% Aug 1, 2016 10-Q 2016-08-04
Q1 2016 27.3M +373K +1.38% May 2, 2016 10-Q 2016-05-05
Q3 2015 27.3M +2.96M +12.2% Nov 3, 2015 10-Q 2015-11-05
Q2 2015 27.3M +3M +12.3% Aug 6, 2015 10-Q 2015-08-10
Q1 2015 27M +2.75M +11.4% Feb 28, 2015 10-K 2015-03-16
Q3 2014 24.3M +6.09M +33.4% Nov 6, 2014 10-Q 2014-11-10
Q2 2014 24.3M +6.07M +33.3% Aug 1, 2014 10-Q 2014-08-07
Q1 2014 24.2M +6.01M +33% May 2, 2014 10-Q 2014-05-08
Q4 2013 18.6M +4.3M +30.1% Jan 31, 2014 10-K 2014-02-27
Q3 2013 18.2M +3.97M +27.8% Nov 4, 2013 10-Q 2013-11-13
Q2 2013 18.2M +3.94M +27.6% Aug 2, 2013 10-Q 2013-08-13
Q1 2013 18.2M May 3, 2013 10-Q 2013-05-15
Q4 2012 14.3M Jan 31, 2013 10-K 2013-02-25
Q3 2012 14.3M Nov 5, 2012 10-Q 2012-11-13
Q2 2012 14.3M Aug 13, 2012 10-Q 2012-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.